Skip to main content

Market Overview

CryoLife to Participate in Oppenheimer 31st Annual Virtual Healthcare Conference

Share:

ATLANTA, March 9, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE:CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in the upcoming Oppenheimer 31st Annual Virtual Healthcare conference on Tuesday, March 16 - 17, 2021.  The Company's virtual fireside chat is scheduled to begin at 11:20 a.m. ET on March 16, 2021.  

A live webcast of the virtual fireside chat will be accessible through CryoLife's website, www.cryolife.com, on the Investor Relations page.  An archived copy of the webcast will be available for 90 days on the same website. 

About CryoLife, Inc.
Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair.  CryoLife markets and sells products in more than 100 countries worldwide.  For additional information about CryoLife, visit our website, www.cryolife.com.

Contacts:

CryoLife       

D. Ashley Lee                                                

Executive Vice President, Chief Financial Officer

and Chief Operating Officer   
Phone: 770-419-3355


Gilmartin Group LLC

Brian Johnston / Lynn Lewis

Phone: 631-807-1986

investors@cryolife.com

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/cryolife-to-participate-in-oppenheimer-31st-annual-virtual-healthcare-conference-301243181.html

SOURCE CryoLife, Inc.

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com